Require Prescription
Description:
Aranesp (darbepoetin alfa) is an erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD) and chemotherapy. It helps to reduce the need for blood transfusions by stimulating the bone marrow to produce more red blood cells.
Ingredients:
Active Ingredient: Darbepoetin Alfa Other Ingredients: Polysorbate 80, Sodium Chloride, Sodium Phosphate Monobasic Monohydrate, Sodium Phosphate Dibasic Anhydrous, Water for Injection
Usage Instructions:
- The dosage of Aranesp depends on the patient's weight, medical condition, and response to treatment.
- Administer as a subcutaneous or intravenous injection as directed by a healthcare provider.
- Typically, it is given once a week or once every two weeks.
- Follow the specific dosage and administration instructions provided by your healthcare provider.
Benefits:
- Treats anemia by increasing red blood cell production.
- Reduces the need for blood transfusions in patients with chronic kidney disease or those undergoing chemotherapy.
- Improves quality of life by alleviating symptoms of anemia, such as fatigue and weakness.
Precautions:
- Do not use if you are allergic to darbepoetin alfa or any of the ingredients in the product.
- Use with caution in patients with uncontrolled hypertension.
- Monitor hemoglobin levels regularly to avoid excessive increases, which may increase the risk of serious cardiovascular events.
- Potential side effects include high blood pressure, blood clots, and injection site reactions.
- Inform your healthcare provider of all medications you are taking, including over-the-counter drugs and supplements.
Storage Instructions:
- Store in the refrigerator at 2°C to 8°C (36°F to 46°F).
- Do not freeze. Protect from light.
- Keep the pre-filled syringes in their original carton until ready to use.
- Do not use if the solution is discolored or contains particles.
Manufacturer:
Amgen Inc.
